Skip to main content

ONO PHARMACEUTICAL CO., LTD.

  • Investors
  • News
  • Contact
  • Japanese
  • Global
  • About
      About
    • Greetings
    • Mission Statement
    • Corporate Governance
    • Management Strategy
    • ONO Story
    • Company Overview
    • Business Activities
    • History
    • Main Products
    • Videos and Advertisements
    • Policies
    • Company Profile
    • Management
    • Business Locations
    • ONO Story
    • R＆D
    • Manufacturing
    • Activities for Disseminating Academic Information
    • Safety and Quality Assurance
    • Digital & IT
    • ONO’s 300-Year History
    • Videos and Advertisements Top
    • "Rising to the challenges of Immuno-Oncology"
    CLOSE
    ONO Story
    ONO Story
    Videos and Advertisements
    Videos and Advertisements
  • R＆D
      R＆D
    • In-house Drug Discovery
    • Open Innovation
    • Licensing Activities
    • Research Organization
    • Development Policy
    • Development Pipeline
    • The investigator-sponsored research support
    • Licensing Activities Top
    • Licensing & Co-promotion
    • Drug discovery partnerships & Research collaborations
    CLOSE
    Development Pipeline
    Development Pipeline
  • Global Business
  • Sustainability
      Sustainability
    • Top Message
    • ONO's Approach to Sustainability
    • Environment
    • Society
    • Governance
    • Stakeholder Engagement
    • Social Contribution Activities
    • Policies
    • GRI Standards Content Index
    • Sustainability Report
    • ESG Data
    • External Evaluation
    • Independent Practitioner's Assurance
    • Commitment to Conservation of the Global Environment
    • Information Disclosure Based on the TCFD Recommendation
    • Realization of a Decarbonized Society
    • Realization of a Water Recycling-oriented Society
    • Realization of a Resource Recycling Society
    • Information Disclosure Based on the TNFD Recommendations
    • Biodiversity
    • EHS Management
    • Environmental Accounting
    • Innovative Pharmaceutical Products
    • Efforts Made for Improving Access to Healthcare
    • Respect for Human Rights
    • Expansion of Human Capital (Talent Development)
    • Expansion of Human Capital (DE&I)
    • Cultivation of Employee-friendly Workplaces/Safety and Health
    • Supply Chain Management
    • Corporate Governance
    • Compliance
    • Risk Management
    • Responsible Promotion Activities
    • Stakeholder Engagement
    • Communication with Investors
    • Cooperation with Governments
    • Social Contribution Activities
    • Efforts for the Advancement of Medicine and Pharmacy
    • Efforts for Supporting Health of Patients and Their Families
    • Efforts Toward Environmental Conservation for the Health of Everyone
    • Efforts Toward an Education for the Children’s Health
    • Efforts for Improvement of the Medical Ecosystem
    CLOSE
    ECO VISION 2050
    ECO VISION 2050
    Improving Access to Healthcare
    Improving Access to Healthcare
icon_search_white icon_close_w
  • About
    • About Top
    • Greetings
    • Mission Statement
    • Corporate Governance
    • Management Strategy
    • ONO Story
    • Company Overview
    • History
    • Main Products
    • Videos and Advertisements
    • Policies
    Business Activities
    • R&D
    • Manufacturing
    • Activities for Disseminating Academic Information
    • Safety and Quality Assurance
    • Digital & IT
  • R＆D
    • R＆D Top
    • In-house Drug Discovery
    • Open Innovation
    • Licensing Activities
    • Research Organization
    • Development Policy
    • Development Pipeline
    • The investigator-sponsored research support
  • Global Business
    • Global Business Top
  • Sustainability
    • Sustainability Top
    • Top Message
    • ONO's Approach to Sustainability
    • Environment
    • Society
    • Governance
    • Stakeholder Engagement
    • Social Contribution Activities
    • Policies
    • GRI Standards Content Index
    • Sustainability Report
    • ESG Data
    • External Evaluation
    • Independent Practitioner's Assurance
icon_search_g
Home Contact

Contact

ONO PHARMACEUTICAL CO., LTD.

  • General Affairs
    Mail：[email protected]

Inquiry regarding compliance

  • Click here for the “ONO Group Compliance Hotline”

*It may take time to respond to inquiries received during our holidays.

  • Official Channel

  • About

    About

    • Greetings
    • Mission Statement
    • Corporate Governance
    • Management Strategy
    • ONO Story
    • Company Overview
    • Business Activities
    • History
    • Main Products
    • Videos and Advertisements
    • Policies

  • R＆D

    R＆D

    • In-house Drug Discovery
    • Open Innovation
    • Licensing Activities
    • Research Organization
    • Development Policy
    • Development Pipeline
    • The investigator-sponsored research support

  • Global Business

    Global Business

  • Sustainability

    Sustainability

    • Top Message
    • ONO's Approach to Sustainability
    • Environment
    • Society
    • Governance
    • Stakeholder Engagement
    • Social Contribution Activities
    • Policies
    • GRI Standards Content Index
    • Sustainability Report
    • ESG Data
    • External Evaluation
    • Independent Practitioner's Assurance
  • Investors
  • News
  • Contact
  • Japanese
  • Global
  • Privacy Policy
  • Terms of Use
  • Site Map
  • Official Channel

COPYRIGHT © 2025 ONO PHARMACEUTICAL CO., LTD.
ALL RIGHTS RESERVED.

GoTo Top